Empirical antimicrobial therapy for bloodstream infection due to methicillin-resistant staphylococcus aureus: No better than a coin toss

Infection Control and Hospital Epidemiology

Volumn 30, Issue 11, 2009, Pages 1057-1061

  Herzke, Carrie A ^a   Chen, Luke F ^b   Anderson, Deverick J ^b   Choi, Yong ^b   Sexton, Daniel J ^b   Kaye, Keith S ^c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; LINEZOLID; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; ARTICLE; BLOOD CULTURE; BLOODSTREAM INFECTION; CENTRAL VENOUS CATHETERIZATION; COHORT ANALYSIS; FECES INCONTINENCE; FEMALE; HEMODIALYSIS; HIP ARTHROPLASTY; HUMAN; KNEE ARTHROPLASTY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOME ASSESSMENT; RISK FACTOR; SCORING SYSTEM; STAPHYLOCOCCUS INFECTION; TREATMENT INDICATION; ARTHROPLASTY; BACTEREMIA; CASE CONTROL STUDY; CLINICAL PRACTICE; CROSS INFECTION; DRUG EFFECTS; EVALUATION STUDY; MICROBIOLOGY; MIDDLE AGED; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME;

AGED; ANTI-BACTERIAL AGENTS; ARTHROPLASTY; BACTEREMIA; CASE-CONTROL STUDIES; CATHETERIZATION, CENTRAL VENOUS; CROSS INFECTION; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME;

EID: 71949093226     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/606163     Document Type: Article

References (22)

1. Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007; 298: 1763-1771.
2. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39:309-317.
3. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005; 26:166-174.
4. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 36:53-59. (Pubitemid 36099097)
5. Engemann JJ, Carmeli Y, Cosgrove SE, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003; 36: 592-598.
6. Roghmann MC. Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia. Arch Intern Med 2000; 160:1001-1004.
7. Shurland S, Zhan M, Bradham DD, Roughmann MC. Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Infect Control Hosp Epidemiol 2007; 28:273-279.
8. Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998; 244:379-386.
9. Kaye KS, Anderson DJ, Choi Y, Link K, Thacker P, Sexton DJ. The deadly toll of invasive methicillin-resistant Staphylococcus aureus infection in community hospitals. Clin Infect Dis 2008; 46:1568-1577.
10. Kaye KS, Schmidt K, Peiper C. The effect of increasing age on the risk of surgical site infection. J Infect Dis 2005; 191:1056-1062.
11. Kaye KS, Sloane R, Sexton DJ, Schmader KA. Risk factors for surgical site infections in older people. J Am Geriatr Soc 2006; 54:391-396.
12. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-383.
13. McCabe W. Gram-negative bacteremia, I: etiology and ecology. Arch Intern Med 1962; 110:847-852.
14. Katz S, Ford AB, Moskowitz RW, Jackson BA, JaffeMW. Studies of illness in the aged: the index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963; 185:914-919.
15. Friedman ND, Kaye KS, Stout JE, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002; 137:791-797.
16. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDCdefinitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128-140.
17. Social Security Index (SSDI). Available at: http://ssdi.rootsweb.com. Accessed December 15, 2007.
18. Edwards C, Counsell A, Boulton C, Moran CG. Early infection after hip fracture surgery: risk factors, costs and outcome. J Bone Joint Surg Br 2008; 90:770-777.
19. Kourbatova EV, Halvosa JS, King MD, Ray SM, White N, Blumberg HM. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections. Am J Infect Control 2005; 33:385-391.
20. Ridgeway S, Wilson J, Charlet A, Kefatos G, Pearson A, Coello R. Infection of the surgical site after arthroplasty of the hip. J Bone Joint Surg Br 2005; 87:844-850.
21. Kim PW, Perl TM, Keelaghan EF, et al. Risk of mortality with a bloodstream infection is higher in the less severely ill at admission. Am J Respir Crit Care Med 2005; 171:616-620.
22. Glenn KR, Craig A, Kainer MA. Thirty-day and 180-day case fatality rates among invasive methicillin-resistant Staphylococcus aureus patients (Tennessee, 2004-2007). In: Program and abstracts of the International Conference on Emerging Infectious Diseases 2008; March 16-19, 2008; Atlanta, GA. Abstract 264.